🏥 VAERS Vaccine Data Browser

🔒 Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

📖 Help & Search Guide

Column Icons Legend

💀 Death
🏥 Hospitalized
🚑 Emergency Room
♿ Disability
⚠️ Life Threatening

How to Search

💡 Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "📥 Export CSV" to download filtered data (max 10,000 records)

💡 Frequently Asked Questions (FAQ)

What is this site?

🏥 VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • ✅ Early warning system for potential safety signals
  • ✅ Open and transparent - publicly accessible
  • ✅ Accepts all reports regardless of likelihood of causation
  • ✅ Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • ⚠️ Reports are unverified - not investigated before publication
  • ⚠️ Cannot determine if vaccine caused the event
  • ⚠️ Underreporting - not all adverse events are reported
  • ⚠️ Overreporting - coincidental events may be reported
  • ⚠️ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

⚠️ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
🔄 Reset 📥 Export CSV
ID Age Sex State Date ▼ Onset Days Vaccine Manufacturer Lot # Symptoms Narrative 💀 🏥 🚑 ♿ ⚠️
2821757 70 M AZ 01/20/2025 COVID19
COVID19
 PFIZER\BIONTECH
PFIZER\BIONTECH
 FJ8762
FJ8762
Acute kidney injury, Asthenia, Breakthrough COVID-19, Dysstasia, Electrolyte imb... Acute kidney injury, Asthenia, Breakthrough COVID-19, Dysstasia, Electrolyte imbalance; SARS-CoV-2 test positive, Upper respiratory tract infection, Ventilation/perfusion scan normal More
Reported Symptoms: 10054115:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084268:COVID... Reported Symptoms: 10054115:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084268:COVID-19; Narrative: Patient presented to the ED due to generalized weakness. He travelled last week, fell sick with URI and then developed generalized weakness on Sat 6/29/24, when he had difficulty standing up. He tested positive for COVID-19 and was found to have AKI and multiple electrolyte abnormalities. Was started on remdesivir, dexamethasone, and IV fluids. Pt improved throughout 3 days and was discharged home. Other Relevant HX: 73-year-old gentleman with a history of HTN, HLD, CKD, CAD, BPH, and anemis who presented to the ER with generalized weakness. Other: Hospitalization due to Covid-19 infection after having received Covid-19 Vaccination More
✓
2821758 28 M AZ 01/20/2025 COVID19
COVID19
COVID19
COVID19
 PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
 ER8735
ER8735
ER8735
ER8735
Breakthrough COVID-19, Chest X-ray normal, Chest pain, Computerised tomogram tho... Breakthrough COVID-19, Chest X-ray normal, Chest pain, Computerised tomogram thorax normal, Echocardiogram normal; Ejection fraction normal, Electrocardiogram ST-T change, Electrocardiogram T wave inversion, Hypophagia, Increased viscosity of bronchial secretion; Nausea, Pain, Presyncope, Productive cough, SARS-CoV-2 test positive; Scan with contrast normal, Sputum discoloured, Viral cardiomyopathy More
Reported Symptoms: 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084268:COVID... Reported Symptoms: 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084268:COVID-19; Narrative: Patient was recently diagnosed with COVID-19 about a week ago and being watched at home. She continues to have cough productive of whitish phlegm but sometimes has dark and thick mucus with it. Today, after a prolonged bout of coughing at home and nearly passing out from it, she decided to come to ED. Has not been eating well or drinking enough in past 3 days due to nausea. Cough provokes soreness of the body and chest pain but denies SOB, orthopnea or new leg swelling. ED evaluation was unremarkable including CXR, but the ECG showed new changes including diffuse ST/T changes involving Inferior leads and T-inversion in the anterior-lateral leads. ECG changes thought to be most likely secondary to COVID19 viral cardiomyopathy. Patient was started on dexamethasone x 7 days in the hospital and was discharged to home. Other Relevant HX: Transgender female with a significant past medical history of PTSD, recurrent major depressive disorder (MDD), asthma, and cannabis dependence, presented to the Emergency Department (ED) after nearly passing out from a prolonged bout of coughing. Other: Hospitalization due to Covid-19 infection after having received Covid-19 Vaccination More
✓
2821759 79 M AZ 01/20/2025 COVID19
COVID19
COVID19
 MODERNA
MODERNA
MODERNA


Arthralgia, COVID-19, Cellulitis, Condition aggravated, Dyspnoea; Gout, Hypervol... Arthralgia, COVID-19, Cellulitis, Condition aggravated, Dyspnoea; Gout, Hypervolaemia, Intensive care, Polyuria, Productive cough; SARS-CoV-2 test positive More
Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: Patient was admitted on A... Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: Patient was admitted on AUG 13, 2024@23:24:54 and discharged Aug 30,2024 Patient is a 83 year old MALE w PMH significant for recent septic shock (Group A strep) due to RLE cellulitis/necrotic ulcer s/p debridement (on vanc and cipro), HFpEF (no records), Afib (on no AC), AAA 4.3cm, COPD, lymphedema, gout who presented to the facility as a transfer from another hospital for celluitus/placement upon discharge. Patient was volume overloaded on admission and aggressively diuresed until he became euvolemic. His R knee pain was treated for gout and eventually improved. Patient became dyspneic with increased cough/sputum and oxygen requirements. He tested positive for COVID and upgraded to ICU for HFNC. He was seen by palliative care who thought the patient did not meet hospice requirements. He was treated with abx and treated with remdesivir/dexamethasone for COVID-19. Pt was discharged back to the hospital facility when he was medically stable. Other Relevant HX: PMH of #acute hypoxic resp failure/ARDS - secondary to COVID pneumonia and HAP- improving #Multilobar Klebsiella Enterobacter PNA with elevated PCT and CRP #Severe pulmonary HTN #COVID + #Hospital acquired pneumonia #COPD #RLE weakness-injury vs deconditioning #RLE cellulitis and necrotic ulcer sp debridement and IV abx #Bilateral Lymphedema #Gout #R knee pain #Septic shock due to group A strep-resolved #HFpEF #Afib #bradycardia #sacral wound #Pancreatic mass #Constipation #HTN #BPH Other: Covid-19 infection during hospitalization More
✓
2821760 71 M AZ 01/20/2025 COVID19-2
 PFIZER\BIONTECH
 HF5017
Breakthrough COVID-19, Cough, Fatigue, SARS-CoV-2 test positive Breakthrough COVID-19, Cough, Fatigue, SARS-CoV-2 test positive
Reported Symptoms: 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084268:COVID... Reported Symptoms: 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084268:COVID-19; Narrative: Patient admitted for worsening faitgue and cough, found to be COVID + and hospitalized for COVID treatment. Discharged home without complications. Other Relevant HX: Other: Hospitalization due to Covid-19 infection after having received Covid-19 vaccination More
✓
2821761 78 F AZ 01/20/2025 COVID19
 PFIZER\BIONTECH
COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Reported Symptoms: 10054115:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084268:COVID... Reported Symptoms: 10054115:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084268:COVID-19; Narrative: Discharged home Other Relevant HX: Other: : Hospitalization due to Covid-19 infection after having received Covid-19 Vaccination More
2821762 1.42 F FL 01/20/2025 HEPA
 MERCK & CO. INC.
 Y006121
Peripheral swelling Peripheral swelling
7 hours following vaccination with hepatitis A vaccine patient started developing significant swelli... 7 hours following vaccination with hepatitis A vaccine patient started developing significant swelling in her hands and in her feet and lower legs. More
2821820 16 M MI 01/20/2025 MNQ
 NOVARTIS VACCINES AND DIAGNOSTICS
 AMVB044A
No adverse event No adverse event
none he had no reaction none he had no reaction
2821821 84 F OH 01/20/2025 COVID19
 MODERNA
 029L2012
Pain in extremity Pain in extremity
arms 1 vaccine in each arm pain in location 3 years getting worse arms 1 vaccine in each arm pain in location 3 years getting worse
2821822 1.25 M ID 01/20/2025 DTAPIPVHIB
HEPA
 SANOFI PASTEUR
GLAXOSMITHKLINE BIOLOGICALS
 UK043AA
Y011643
Wrong product administered; Wrong product administered Wrong product administered; Wrong product administered
Patient was given a second Hep A vaccine that was not supposed to be given. He was to get a Prevnar,... Patient was given a second Hep A vaccine that was not supposed to be given. He was to get a Prevnar, but a Hep A was accidentally pulled and administered instead. More
2821823 62 F VA 01/20/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
Paraesthesia, Vertigo Paraesthesia, Vertigo
(Personal hx shingles 2009 affecting right side of head/face, tx zovirax within 1st hr of 1st lesion... (Personal hx shingles 2009 affecting right side of head/face, tx zovirax within 1st hr of 1st lesion and limited to 3 lesions. ) Post vax day 2, unexpected vertigo late afternoon, seemingly left leaning resolved after full night's sleep. No fevers or chills. Post vax day 3 noted tingling scalp occipital area, along single line of where I had shingles 2009, but no actual lesions noted, just tingling. More
2821824 63 F FL 01/20/2025 MMR
 MERCK & CO. INC.
 y009430
Extra dose administered Extra dose administered
Additional dose administered Additional dose administered
2821825 41 F MA 01/20/2025 HEP
 GLAXOSMITHKLINE BIOLOGICALS
 FP9TJ
No adverse event, Underdose No adverse event, Underdose
Adult patient was administered a pediatric dose in error . Patient was informed and the provider was... Adult patient was administered a pediatric dose in error . Patient was informed and the provider was informed. No side effects or adverse effect noted. Patient will be booked for an appointment for the full dose More
2821826 26 M MN 01/20/2025 FLU3
FLU3
TDAP
TDAP
 SANOFI PASTEUR
SANOFI PASTEUR
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS



Cough, Fatigue, Influenza virus test negative, Oropharyngeal pain, Pyrexia; SARS... Cough, Fatigue, Influenza virus test negative, Oropharyngeal pain, Pyrexia; SARS-CoV-2 test negative; Cough, Fatigue, Influenza virus test negative, Oropharyngeal pain, Pyrexia; SARS-CoV-2 test negative More
Fever, fatigue, cough, sore throat Fever, fatigue, cough, sore throat
2821827 75 F TX 01/20/2025 COVID19
COVID19
COVID19
COVID19
 PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
 LP1780
LP1780
LP1780
LP1780
Blood pressure increased; Blood pressure increased, Dizziness; Blood pressure in... Blood pressure increased; Blood pressure increased, Dizziness; Blood pressure increased; Blood pressure increased, Dizziness More
12/23/24 elevated BP started 1/7/2025 172/106; BP still variable 12/23/24 elevated BP started 1/7/2025 172/106; BP still variable
2821828 34 F CA 01/20/2025 RAB
 NOVARTIS VACCINES AND DIAGNOSTICS
Feeling of body temperature change, Paraesthesia Feeling of body temperature change, Paraesthesia
Left arm, face and leg paresthesia with preserved reflexes, altered temperature sensation within 10... Left arm, face and leg paresthesia with preserved reflexes, altered temperature sensation within 10 minutes or administration. More
2821829 0.5 M CO 01/20/2025 DTAPIPVHIB
 SANOFI PASTEUR
 UK044AA
No adverse event, Product preparation issue No adverse event, Product preparation issue
Patient was in for 6 month wcc. And provider ordered a Pentacel, patient was then given the pentacel... Patient was in for 6 month wcc. And provider ordered a Pentacel, patient was then given the pentacel but the vaccine vials were not mixed and was only given the Dtap and Polio portion. MOC was notified the same day about the vaccine error and informed to come back at earliest convience to recieve the HIB portion of the vaccine. MOC states that she will come back within the next 1-2 weeks to recieve vaccine. There were no additional side affects presented by parents after recieving vaccine. More
2821830 1 M AR 01/20/2025 HEPA
HEPA
HIBV
HIBV
MMR
MMR
PNC20
PNC20
VARCEL
VARCEL
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
SANOFI PASTEUR
SANOFI PASTEUR
MERCK & CO. INC.
MERCK & CO. INC.
PFIZER\WYETH
PFIZER\WYETH
MERCK & CO. INC.
MERCK & CO. INC.
 BM4R5
BM4R5
UJ992AA
UJ992AA
X026329
X026329
HP7365
HP7365
X026319
X026319
Condition aggravated, Fatigue, Hypersensitivity, Injection site reaction, Inject... Condition aggravated, Fatigue, Hypersensitivity, Injection site reaction, Injection site swelling; Malaise, Milk allergy, Rash vesicular, Vomiting; Condition aggravated, Fatigue, Hypersensitivity, Injection site reaction, Injection site swelling; Malaise, Milk allergy, Rash vesicular, Vomiting; Condition aggravated, Fatigue, Hypersensitivity, Injection site reaction, Injection site swelling; Malaise, Milk allergy, Rash vesicular, Vomiting; Condition aggravated, Fatigue, Hypersensitivity, Injection site reaction, Injection site swelling; Malaise, Milk allergy, Rash vesicular, Vomiting; Condition aggravated, Fatigue, Hypersensitivity, Injection site reaction, Injection site swelling; Malaise, Milk allergy, Rash vesicular, Vomiting More
Patient was very sick for about two weeks after receiving this round of shots, left leg was swollen ... Patient was very sick for about two weeks after receiving this round of shots, left leg was swollen and broke out in a terrible spotty rash, almost looked like chicken pox. I have photos that can be attached. He was very tired, lots of throwing up. I spoke with the mother of patient and she said she was told that this was normal. I do not believe that it is and he was very sick. He has been sick multiple times since receiving this round of shots. More
2821831 64 M NY 01/20/2025 PNC20
RSV
 PFIZER\WYETH
PFIZER\WYETH
 lg5579
ln5466
Palpitations; Palpitations Palpitations; Palpitations
experienced palpitations for a few days after vaccination experienced palpitations for a few days after vaccination
2821833 1.25 F MI 01/20/2025 DTAP
HIBV
PNC20
 SANOFI PASTEUR
SANOFI PASTEUR
PFIZER\WYETH
 3CA11C1
UK019AA
LJ5281
Unevaluable event; Unevaluable event; Unevaluable event Unevaluable event; Unevaluable event; Unevaluable event
NONE NOTED NONE NOTED
2821834 58 M MO 01/20/2025 COVID19
 PFIZER\BIONTECH
 EW0172
Pain in extremity, Peripheral swelling Pain in extremity, Peripheral swelling
Swollen and sore arm Swollen and sore arm
✓
2821835 14 F NJ 01/20/2025 FLU3
 GLAXOSMITHKLINE BIOLOGICALS
 4LM54
Extra dose administered Extra dose administered
Pt received a second dose of flu by mistake. First dose was on 11/2024 Pt received a second dose of flu by mistake. First dose was on 11/2024
2821836 19 F OH 01/20/2025 COVID19
 MODERNA
Abortion spontaneous, Maternal exposure before pregnancy, Pregnancy test Abortion spontaneous, Maternal exposure before pregnancy, Pregnancy test
3 miscarriages after vaccines. 1st vaccine: 02/26/2021, miscarriage 07/2021, 2nd vaccine: 9/15/2021,... 3 miscarriages after vaccines. 1st vaccine: 02/26/2021, miscarriage 07/2021, 2nd vaccine: 9/15/2021, 3rd vaccine: 10/13/2021, 2nd miscarriage 01/2022, 3rd miscarriage: 05/2022 More
2821837 89 F FL 01/20/2025 FLU3
 SEQIRUS, INC.
 946591
Death Death
Resident had Flu and Prevnar 20 vaccine on 1/18/2025 at around 9am Resident had Flu and Prevnar 20 vaccine on 1/18/2025 at around 9am
✓
2821838 0.17 F OH 01/20/2025 DTAPIPVHIB
 SANOFI PASTEUR
 UK137AA
Wrong product administered Wrong product administered
Patient should have received Pediarix, I accidentally gave the Pentacel . My fault. Was thinking i... Patient should have received Pediarix, I accidentally gave the Pentacel . My fault. Was thinking it contained the Hepatitis b instead of the Hib. More
2821839 74 F FL 01/20/2025 RSV
 GLAXOSMITHKLINE BIOLOGICALS
 255t2
Extra dose administered, No adverse event Extra dose administered, No adverse event
Gave RSV shot not realizing that she had already received on 9/22/23. Talked to patient, and she did... Gave RSV shot not realizing that she had already received on 9/22/23. Talked to patient, and she did not feal any different and is fine. More
2821840 84 F NC 01/20/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 D5AP5
Injection site pain, Muscular weakness, X-ray Injection site pain, Muscular weakness, X-ray
Patient called and spoke to pharmacist on 1/20/25 to report had noticed arm pain in Right arm in whe... Patient called and spoke to pharmacist on 1/20/25 to report had noticed arm pain in Right arm in where she received 2nd shingrix vaccine on 9/12/24. System has reported as administration into Left arm but patient states remembers getting in right arm since she had a previous masectomy and avoids getting vaccines in left arm so it was in the right arm. She went to her medical MD and they did an Xray since pain was not resolving and patient then was referred to physical therapy. Did one session of physical therapy as of last week. Patient reports weakness and pain (like a toothache where it hurts all the time) in the right arm. She is using Salonpas and takes Advil for pain. She called to report this adverse event to pharmacy More
2821841 65 F FL 01/20/2025 PNC20
PNC20
 PFIZER\WYETH
PFIZER\WYETH
 LJ5281
LJ5281
Cellulitis, Erythema, Heart rate increased, Influenza like illness, Pyrexia; Ski... Cellulitis, Erythema, Heart rate increased, Influenza like illness, Pyrexia; Skin warm, Swelling More
Patient developed swelling, redness and warm to touch reaction about 3 days after shot was given. L... Patient developed swelling, redness and warm to touch reaction about 3 days after shot was given. Later developed fever and flu like symptoms. ER Doctor diagnosed her with Cellulitis after patient went in More
2821842 73 F FL 01/20/2025 FLU3
PNC20
 SEQIRUS, INC.
PFIZER\WYETH
 388488
LC5482
Extra dose administered; Extra dose administered Extra dose administered; Extra dose administered
Duplicate Prevnar 20 vaccine. The system did not flag previous vaccination, and it does not show the... Duplicate Prevnar 20 vaccine. The system did not flag previous vaccination, and it does not show the 1/28/2023 vaccine in state shots. First dose was 1/28/2023, second dose given 1/16/2025. More
2821843 4 M MS 01/20/2025 DTAPIPV
FLU3
MMRV
 SANOFI PASTEUR
SANOFI PASTEUR
MERCK & CO. INC.
 U7931AB
UT8415LA
Y006783
Injection site erythema, Injection site induration, Injection site pain, Injecti... Injection site erythema, Injection site induration, Injection site pain, Injection site swelling, Injection site warmth; Injection site erythema, Injection site induration, Injection site pain, Injection site swelling, Injection site warmth; Injection site erythema, Injection site induration, Injection site pain, Injection site swelling, Injection site warmth More
4.25 CM X 3.50 CM INDURATED, ERYTHEMATOUS, WARM AREA TO RIGHT THIGH, TENDER TO TOUCH. PER DAD - NOTE... 4.25 CM X 3.50 CM INDURATED, ERYTHEMATOUS, WARM AREA TO RIGHT THIGH, TENDER TO TOUCH. PER DAD - NOTED TO HAVE SWOLLEN, RED, AND WARM AREA TO RIGHT THIGH WHEN HE WAS PICKED UP FROM SCHOOL AROUND 3PM ON 1/14/2025. AREA GOT BIGGER OVERNIGHT. NO FEVER. NO RESPIRATORY SYMPTOMS. NO NAUSEA, VOMITING, OR DIARRHEA. TREATMENT WITH CETIRIZINE QAM AND BENADRYL QPM, PRN HYDROCORTISONE CREAM FOR ITCHING. More
2821844 11 F 01/20/2025 COVID19
 PFIZER\BIONTECH
 LN0589
Incorrect dose administered, No adverse event Incorrect dose administered, No adverse event
Patient was given an adult Pfizer (12+) vaccine when pt should have been given the pediatric Pfizer ... Patient was given an adult Pfizer (12+) vaccine when pt should have been given the pediatric Pfizer vaccine. No adverse effects were reported by patient's parent. More
2821845 74 F SC 01/20/2025 COVID19
FLU3
 PFIZER\BIONTECH
SEQIRUS, INC.

Hypertension; Hypertension Hypertension; Hypertension
High blood pressure High blood pressure
2821846 44 F FL 01/20/2025 HPV9
PNC20
TDAP
 MERCK & CO. INC.
PFIZER\WYETH
GLAXOSMITHKLINE BIOLOGICALS


Injection site erythema, Injection site pain, Pain; Injection site erythema, Inj... Injection site erythema, Injection site pain, Pain; Injection site erythema, Injection site pain, Pain; Injection site erythema, Injection site pain, Pain More
An area of redness and muscle pain on the left upper arm failed to resolve about an inch beneath the... An area of redness and muscle pain on the left upper arm failed to resolve about an inch beneath the injection site. Pain in the mid left upper arm has continued for for days now. Pain increases when raising left arm above head. No issues with the vaccine administered in the right arm. More
2821847 68 F NJ 01/20/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
Herpes zoster, Rash, Rash pruritic Herpes zoster, Rash, Rash pruritic
Recieved vaccine at 4:00 pm on 1/17/25. By 1:00 pm (less than 24 hours) on 1/18/25, observed a rash ... Recieved vaccine at 4:00 pm on 1/17/25. By 1:00 pm (less than 24 hours) on 1/18/25, observed a rash on stomach. Itchy and painful. By 1/19/25 rash increased in size and pain intensified. Saw family doctor on 1/20/25 at 2:00 pm, who confirmed it was shingles and immediately prescribed Valacyclovir. Have never had shingles before. Physician: Dr. More
2821848 0.17 F PA 01/20/2025 DTPPVHBHPB
FLU3
PNC20
RV5
 MSP VACCINE COMPANY
GLAXOSMITHKLINE BIOLOGICALS
PFIZER\WYETH
MERCK & CO. INC.
 U7907AA
AE2J7
LC5483
Y003996
Product administered to patient of inappropriate age, Wrong patient received pro... Product administered to patient of inappropriate age, Wrong patient received product; Product administered to patient of inappropriate age, Wrong patient received product; Product administered to patient of inappropriate age, Wrong patient received product; Product administered to patient of inappropriate age, Wrong patient received product More
Given flulavel that was on the tray to give the older sibling. Given flulavel that was on the tray to give the older sibling.
2821849 4 M TX 01/20/2025 MMRV
 MERCK & CO. INC.
 X018814
Expired product administered, No adverse event Expired product administered, No adverse event
Expired Vaccine, No adverse reaction Expired Vaccine, No adverse reaction
2821850 78 F OH 01/20/2025 RSV
 PFIZER\WYETH
 LN5463
Erythema, Pain in extremity, Peripheral swelling, Skin discolouration Erythema, Pain in extremity, Peripheral swelling, Skin discolouration
PATIENT STATED THAT HER ARM WAS RED, PAINFUL, AND SWOLLEN AFTER RECEIVING HER VACCINATION. IT IS ST... PATIENT STATED THAT HER ARM WAS RED, PAINFUL, AND SWOLLEN AFTER RECEIVING HER VACCINATION. IT IS STILL SORE 3 WEEKS AFTER RECEIVING THE VACCINATION. THERE IS AN AREA THAT IS DISCOLORED ON HER ARM, BUT IS LOWER THAN WHERE THE PATIENT STATES THAT THE VACCINE WAS GIVEN More
2821851 17 M GA 01/20/2025 HPV9
HPV9
HPV9
HPV9
MENB
MENB
 MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
NOVARTIS VACCINES AND DIAGNOSTICS
NOVARTIS VACCINES AND DIAGNOSTICS
 Y000205
Y000205
Y000205
Y000205
3L339
3L339
Cold sweat, Presyncope; Syncope; Cold sweat, Presyncope; Syncope; Cold sweat, Pr... Cold sweat, Presyncope; Syncope; Cold sweat, Presyncope; Syncope; Cold sweat, Presyncope; Syncope More
Patient was given HPV vaccination by medical assistant and within five minutes of receiving the vacc... Patient was given HPV vaccination by medical assistant and within five minutes of receiving the vaccination, he walked up to front desk, became clammy, and had vasovagal episode-- he did not injure himself during vasovagal event lasting less than a minute-- vitals were normal on recheck. He went to ER for further evaluation More
2821852 72 M TN 01/20/2025 RSV
 GLAXOSMITHKLINE BIOLOGICALS
 255T2
Extra dose administered, No adverse event Extra dose administered, No adverse event
Patient presented to pharmacy to request vaccine and it was administered. It was by discovered by ou... Patient presented to pharmacy to request vaccine and it was administered. It was by discovered by our clinical service team that patient had received same vaccine on 11/29/2023. It was no longer in local pharmacy records. Spoke with pt on 1/19/25 and pt did not recall receiving and did not report any adverse events. More
2821854 15 M CA 01/20/2025 HEP
HEP
HEP
HEP
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 X006977
X006977
X006977
X006977
Antibody test negative, Antinuclear antibody positive, Arthralgia, Blood calcium... Antibody test negative, Antinuclear antibody positive, Arthralgia, Blood calcium normal, Blood creatine phosphokinase increased; Blood parathyroid hormone normal, Brain fog, Epstein-Barr virus antibody positive, Epstein-Barr virus antigen positive, Epstein-Barr virus infection; Lymphadenopathy, Malaise, Muscular weakness, Pain, Pyrexia; Rheumatoid factor negative, Urticaria More
Episodic fever, lymph node enlargement, subjective muscle weakness, hives, joint pains without physi... Episodic fever, lymph node enlargement, subjective muscle weakness, hives, joint pains without physical findings, mental fogginess, body aches, malaise More
2821855 66 M FL 01/20/2025 RSV
 GLAXOSMITHKLINE BIOLOGICALS
 255t2
Extra dose administered, No adverse event Extra dose administered, No adverse event
Patient received second dose of vaccine wasn't aware he received a first dose. Was advised by h... Patient received second dose of vaccine wasn't aware he received a first dose. Was advised by his MD to get one. Patient states he is fine no adverse. effects. No hospital or doctor visit required. More
2821856 0.42 F IN 01/20/2025 MMRV
 MERCK & CO. INC.
 Y009106
Product administered to patient of inappropriate age Product administered to patient of inappropriate age
None at this time None at this time
2821857 11 F MA 01/20/2025 MNQ
TDAP
 NOVARTIS VACCINES AND DIAGNOSTICS
SANOFI PASTEUR
 EK7DG
3CA22C1
Erythema, Pruritus, Skin warm; Erythema, Pruritus, Skin warm Erythema, Pruritus, Skin warm; Erythema, Pruritus, Skin warm
Redness, itchy, warm to the touch Redness, itchy, warm to the touch
2821858 0.33 F UT 01/20/2025 DTPPVHBHPB
PNC15
RV5
 MSP VACCINE COMPANY
MERCK & CO. INC.
MERCK & CO. INC.


Eyelid ptosis, Lethargy, Visual impairment; Eyelid ptosis, Lethargy, Visual impa... Eyelid ptosis, Lethargy, Visual impairment; Eyelid ptosis, Lethargy, Visual impairment; Eyelid ptosis, Lethargy, Visual impairment More
The evening of the vaccinations she began to have a droopy right eye. The symptoms lasted about 30 m... The evening of the vaccinations she began to have a droopy right eye. The symptoms lasted about 30 minutes and resolved. 3 days later she had another event of droopy eye that lasted 2+ hours. Her vision seemed affected and had slight bouts of lethargy More
2821859 17 F IN 01/20/2025 MNQ
 NOVARTIS VACCINES AND DIAGNOSTICS
 AMVA982A
Expired product administered Expired product administered
Expired 1031/2024 Expired 1031/2024
2821868 0.17 U CA 01/20/2025 RV5
 MERCK & CO. INC.
Inappropriate schedule of product administration, No adverse event Inappropriate schedule of product administration, No adverse event
ROTATEQ vaccine at 8 weeks old and came back at 28 weeks old to the HCP's office without receiv... ROTATEQ vaccine at 8 weeks old and came back at 28 weeks old to the HCP's office without receiving the second dose of the ROTATEQ vaccine; No additional AE; This spontaneous report was received from a pharmacist and refers to an infant patient of unknown age (reported as 28 weeks old at the time of healthcare professional's (HCP) office visit) and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date (at 8 weeks old), the patient was vaccinated with Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) administered orally (dose, lot # and expiration date were not reported) for prophylaxis. On an unknown date (at 28 weeks old), the patient returned to HCP's office without receiving the second dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) (inappropriate schedule of product administration). No additional adverse event was reported. Lot # was requested and will be provided if available. More
2821869 11 U OR 01/20/2025 MMRV
 MERCK & CO. INC.
 X018570
Expired product administered, No adverse event Expired product administered, No adverse event
No adverse side effects were reported/ No additional AE; PROQUAD vaccine that expired 1/5/2025 and w... No adverse side effects were reported/ No additional AE; PROQUAD vaccine that expired 1/5/2025 and was administered to a patient on 1/15/2025; This spontaneous report was received from Other Health Professional and refers to an 11-year-old patient of unknown gender. The patient's medical history and concurrent conditions were not provided. The patient's concomitant medications included sterile diluent (MERCK STERILE DILUENT). On 15-JAN-2025, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) injection (recombinant Human albumin), lot #X018570, expiration date: 05-JAN-2025, administered for prophylaxis (strength, and route of administration were not provided) (Expired product administered). No adverse side effects were reported. More
2821870 U NE 01/20/2025 HEPA
 MERCK & CO. INC.
No adverse event, Product dose omission issue No adverse event, Product dose omission issue
Pharmacist called stating a 60 year old patient received their 1st dose of VAQTA on 2/14/2023 but mi... Pharmacist called stating a 60 year old patient received their 1st dose of VAQTA on 2/14/2023 but missed their 2nd dose.; No additional AE/no PQC reported.; This spontaneous report was received from a pharmacist and refers to a 60-year-old patient of unknown gender. The patient's medical history, concurrent conditions, concomitant therapies, drug rection or allergies were not reported. On 14-FEB-2023, the patient was vaccinated with the first dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 1 adult dose, administered for prophylaxis (dose, lot number, expiration date, and route of administration were not provided), but missed their second dose (product dose omission issue). Caller stated the patient has not had any symptoms. No additional adverse event (AE) reported. More
2821871 5 F GA 01/20/2025 DTAPIPV
MMRV
 GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
Y005000
Discomfort, Product storage error, Swelling; Discomfort, Product storage error, ... Discomfort, Product storage error, Swelling; Discomfort, Product storage error, Swelling More
Discomfort; Swelling; This spontaneous report was received from a licensed practical nurse and refer... Discomfort; Swelling; This spontaneous report was received from a licensed practical nurse and refers to a 5-year-old female. The patient has no pre-existing allergies, birth defects of medical conditions nor illness at the time of vaccination. None adverse events following a prior vaccination. The patient's concomitant therapies were not reported. On 05-AUG-2024, the patient was vaccinated with the first dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) subcutaneous injection, lot #Y005000, expiration date: 26-AUG-2025, administered subcutaneously in the left arm for prophylaxis; and with the first dose of diphtheria vaccine toxoid, pertussis vaccine acellular 3-component, polio vaccine inact 3v (vero), tetanus vaccine toxoid (KINRIX), lot #1145R, expiration date: 22-AUG-2025, administered intramuscularly in the right arm (formulation and indication were not provided). It was reported that during the day of the vaccine administration, there was a power loss for approximately 2 hours; however, the vaccines were moved to another refrigerator and freeze before they reached the excursion point. All safety guidelines were followed and the vaccines were safe and kept the temperature range. It was reported that the patient's response to the vaccines was normal; however, on an unspecified day in 2024, she experienced swelling and discomfort. No treatment was given for the events. At the time of reporting, the outcome of the events was not known. The causal relationship between the events and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) and diphtheria vaccine toxoid, pertussis vaccine acellular 3-component, polio vaccine inact 3v (vero), tetanus vaccine toxoid (KINRIX) was unknown. This is one of several reports from the same source.; Sender's Comments: US-009507513-2501USA004806: More
2821873 0.25 F 01/20/2025 DTAPHEPBIP
DTAPHEPBIP
HIBV
HIBV
PNC13
PNC13
RV1
RV1
UNK
UNK
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
PFIZER\WYETH
PFIZER\WYETH
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
 UNK
UNK
UNK
UNK
UNK
UNK
UNK
UNK
UNK
UNK
Chest X-ray abnormal, Cough, Decreased appetite, Dyspnoea, Hypoxia; Oxygen satur... Chest X-ray abnormal, Cough, Decreased appetite, Dyspnoea, Hypoxia; Oxygen saturation decreased, Pneumonia bacterial, Pyrexia, Rhinorrhoea, Vomiting; Chest X-ray abnormal, Cough, Decreased appetite, Dyspnoea, Hypoxia; Oxygen saturation decreased, Pneumonia bacterial, Pyrexia, Rhinorrhoea, Vomiting; Chest X-ray abnormal, Cough, Decreased appetite, Dyspnoea, Hypoxia; Oxygen saturation decreased, Pneumonia bacterial, Pyrexia, Rhinorrhoea, Vomiting; Chest X-ray abnormal, Cough, Decreased appetite, Dyspnoea, Hypoxia; Oxygen saturation decreased, Pneumonia bacterial, Pyrexia, Rhinorrhoea, Vomiting; Chest X-ray abnormal, Cough, Decreased appetite, Dyspnoea, Hypoxia; Oxygen saturation decreased, Pneumonia bacterial, Pyrexia, Rhinorrhoea, Vomiting More
Bacterial Pneumonia; This 12-month-old female subject was enrolled in a study. The subject received ... Bacterial Pneumonia; This 12-month-old female subject was enrolled in a study. The subject received the 3rd dose of Bexsero vs Placebo (intramuscular, right thigh) on 24-OCT-2022, for prophylaxis. The subject received the 3rd dose of Hiberix (intramuscular, right thigh) on 24-OCT-2022, for prophylaxis. The subject received the 3rd dose of DTPa-HBV-IPV (intramuscular, left thigh) on 24-OCT-2022, for prophylaxis. The subject received the 2nd dose of Rotarix lyophilized formulation (oral) on 21-JUL-2022, for prophylaxis. Co-suspect products included Prevenar 13 (Non-GSK Comparator) (Prevenar 13) for prophylaxis. The subject's past medical history included upper respiratory tract infection, respiratory syncytial virus infection and viral upper respiratory tract infection (with cough). Concurrent medical conditions included upper respiratory tract infection. On 31-MAR-2023, 158 days after receiving Bexsero vs Placebo, Hiberix and DTPa-HBV-IPV and 253 days after receiving Rotarix lyophilized formulation, the subject developed severe - grade 3 pneumonia bacterial (Verbatim: Bacterial Pneumonia). Serious criteria included hospitalization. The subject was treated with salbutamol (Albuterol), amoxicillin, ceftriaxone sodium (Rocephin) and oxygen. Bexsero vs Placebo was continued with no change. The outcome of pneumonia bacterial was resolved on 13-APR-2023. Diagnostic results (reference ranges are provided in parenthesis if available): Chest X-ray-In APR-2023 with viral appearance, no focal infiltrate. The investigator considered that there was no reasonable possibility that the pneumonia bacterial may have been caused by Bexsero vs Placebo, Hiberix, DTPa-HBV-IPV and Rotarix lyophilized formulation. The company considered that there was no reasonable possibility that the pneumonia bacterial may have been caused by Bexsero vs Placebo, Hiberix, DTPa-HBV-IPV and Rotarix lyophilized formulation. GSK Receipt Date: 17-APR-2023. Subject was a 1 year old female with history of recurrent viral illnesses this past year including Respiratory Syncytial Virtus but no prior hospitalization. They presented with a 2 day history of cough and fever preceded by runny nose for a few days prior to onset of cough. Treated with tylenol for fevers. Subject was nursing frequently, but otherwise with decrease appetite, emesis couple times with coughing. Mom noted some increased work of breathing and checked sats with owlette at home with sats in the low 80's prompting visit to the Emergency room (ER) on 4/2/23. In the ER, was initially noted to be setting fine on room air, but upon falling asleep dropped to mid 80's. Albuterol nebulizer was administered but no significant response as no wheezing was noted. Subject was admitted to pediatrics for observation. Event clinical details noted above. Event diagnosis was hypoxia. Concurrent conditions viral upper respiratory infection and bacterial pneumonia. Concomitant medications included oxygen, rocephin, and amoxicillin. Subject was admitted to hospital on 4/2/23 and discharged on 4/3/23 Follow-up information received on 24-Apr-2023 and 01-May-2023. Summary of changes: Narrative updated. Follow-up information received on 10-MAY-2023 and 16-MAY-2023. Summary of changes: Treatment medications (Oxygen, Rocephin, Amoxicillin), narrative, hospitalization dates were updated. Follow-up information received on 17-MAY-2023. Summary of changes: Treatment medication (Albuterol) was updated. Follow-up information received on 20-JUN-2023. Summary of changes: Event term was updated from "hypoxia" to "Pneumonia", Emergency Room Visit ticked. Follow-up information received on 11-jul-2023. Summary of changes: past medical history added. Follow-up information received on 23-AUG-2023. Summary of changes: Treatment medication end date was updated (Rocephin). Follow up information received on 13Sep2023. Summary of changes: Indication updated for Amoxicillin hypoxia to pneumonia. Follow up information received on 30-Oct-2023. Summary of changes: Historical condition of viral upper respiratory tract infection (with cough) added. Follow up information received on 13-FEB-2024. Summary of changes: general narrative updated. Follow-up information received on 22-AUG-2024 Summary of changes: Dose, unit for treatment drug Amoxicillin was updated. Follow up information received on: 20-NOV-2024 Summary of changes: Dose and unit for treatment drug Albuterol was updated. Follow up information received on: 06-JAN-2025 Summary of changes: Dose for treatment drug Albuterol was updated from 0.0 to Unknown Upon internal review the case was updated on 08-JAN-2025, The action taken with Prevnar vaccine was changes from not applicable to no change. Follow up information received on: 14-JAN-2025 Summary of changes: General narrative comments updated, Event start date updated, Relevant medical condition Viral Upper Respiratory Infection with cough start date updated, Event term updated from Pneumonia to Bacterial pneumonia, TTO updated.; Sender's Comments: A case of Pneumonia bacterial, 158 days after receiving 3rd dose of Bexsero vs Placebo, 3rd dose of Prevnar 13, 3rd dose of DTPa-HBV-IPV ,the 3rd dose of Hiberix, and 253 days after receiving 2nd dose of Rotarix lyophilized formulation, in 12-month-old female subject. Report is inconsistent with causal relation to the vaccine product, considering implausible time to onset and absence of biological plausibility and alternative risk factor (h/o upper respiratory tract infection, respiratory syncytial virus infection ). More
✓
2821874 F 01/20/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Injection site erythema, Injection site pain, Injection site swelling, Injection... Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth More
red at the injection site; swollen at the injection site; sore at the injection site; arm is also wa... red at the injection site; swollen at the injection site; sore at the injection site; arm is also warm at the injection site; This non-serious case was reported by a consumer and described the occurrence of injection site pain in a 57-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix with an associated reaction of no reaction on previous exposure to drug (received 1st dose of vaccine on an unknown date). Concomitant products included metformin hydrochloride (Metformin) and losartan potassium (Losartan). On 21-DEC-2024, the patient received the 2nd dose of Shingrix .5 ml. In DEC-2024, an unknown time after receiving Shingrix, the patient experienced injection site warmth (Verbatim: arm is also warm at the injection site). On 22-DEC-2024, the patient experienced injection site pain (Verbatim: sore at the injection site). On 23-DEC-2024, the patient experienced injection site erythema (Verbatim: red at the injection site) and injection site swelling (Verbatim: swollen at the injection site). The outcome of the injection site pain, injection site erythema and injection site swelling were not resolved and the outcome of the injection site warmth was not reported. It was unknown if the reporter considered the injection site pain, injection site erythema, injection site swelling and injection site warmth to be related to Shingrix. It was unknown if the company considered the injection site pain, injection site erythema, injection site swelling and injection site warmth to be related to Shingrix. Additional Information: GSK Receipt Date: 24-DEC-2024 Patient reported for soreness (From: 22 Dec 2024 To: Ongoing) Dates for Redness: (From: 23 Dec 2024 To: Ongoing) Dates for Swelling arm: (From: 23 Dec 2024 To: Ongoing). Patient did not had a reaction to the first shingles shot. The second shot patient arm was sore, red and swollen at the injection site. Patient arm was also warm at the injection site. It had been a couple of days since the second Shingles shot. Patient had not been able to locate what need to do to reduce the swelling nor how long it will last. Soreness symptoms not treated. Redness symptoms not treated. Swelling arm not treated. More
📋 Privacy Policy & Data Disclaimer